Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Scilex Holding Company (SCLX) has provided an update.
Scilex Holding Company’s subsidiary and Sorrento Therapeutics filed a lawsuit alleging breaches and misappropriation by the former President of Scilex Pharma, Anthony Mack, and his company, Virpax Pharmaceuticals. A settlement reached with Virpax includes payments totaling $6 million and future royalties on certain drug sales, while litigation against Mack continues. The company recently received a $2.5 million payment as part of the settlement agreement.
For detailed information about SCLX stock, go to TipRanks’ Stock Analysis page.